December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Raghav Sundar: Understanding Resistance Mechanisms in HER2+ Gastric Cancer
Nov 11, 2024, 03:14

Raghav Sundar: Understanding Resistance Mechanisms in HER2+ Gastric Cancer

Raghav Sundar, Leader Gastroesophageal Cancer Program, Associate Professor of Medicine (Oncology), Yale University School of Medicine and Yale Cancer Center, posted the following on X:

“Cancers develop resistance to targeted therapies. Most studies on acquired resistance have focused on tumor cells and not the microenvironment. We outline spatial mechanisms of resistance to trastuzumab and T-DXd in HER2+ Gastric Cancer.”

Spatial Profiling of Patient-Matched HER2 Positive Gastric Cancer Reveals Resistance Mechanisms to Trastuzumab and Trastuzumab Deruxtecan

Authors: Taotao Sheng, Raghav Sundar, Supriya Srivastava, Xuewen Ong, Su Ting Tay, Haoran Ma, Tomoyuki Uchihara, Benedict Shi Xiang Lian, Takeshi Hagihara, Chang Xu, Shamaine Wei Ting Ho, Kie Kyon Huang, Angie Lay Keng Tan, Michelle Shu Wen NG, Ng Shi Ya Clara, Vincenzo Nasca, Chiara Carlotta Pircher, Giovanni Randon, Silvia Giordano, Simona Corso, Jeffrey Huey Yew Lum, Ming Teh, Jimmy Bok Yan So, Jessica Gasparello, Matteo Fassan, Filippo Pietrantonio, Patrick Tan

Raghav Sundar: Understanding Resistance Mechanisms in HER2+ Gastric Cancer